Genasense® (G3139, oblimersen sodium)

DRUG2 trials

Sponsors

Genta Incorporated

Conditions

Advanced MelanomaAdvanced Melanoma and Normal or ImpairedHepatic Function

Phase 1

A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

CompletedNCT00542893

Genta IncorporatedAdvanced Melanoma

Start: 2006-04-30End: 2007-09-30Updated: 2012-03-13

Phase 2

Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

TerminatedNCT00543205

Genta IncorporatedAdvanced Melanoma and Normal or Impaired, Hepatic Function

Start: 2005-08-31End: 2007-05-31Updated: 2011-11-07